Free Trial

STAAR Surgical (STAA) Stock Price, News & Analysis

STAAR Surgical logo
$18.68 -0.09 (-0.48%)
Closing price 04:00 PM Eastern
Extended Trading
$18.68 0.00 (-0.01%)
As of 05:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About STAAR Surgical Stock (NASDAQ:STAA)

Key Stats

Today's Range
$18.05
$18.74
50-Day Range
$15.09
$20.27
52-Week Range
$13.50
$49.86
Volume
689,190 shs
Average Volume
823,659 shs
Market Capitalization
$925.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$24.63
Consensus Rating
Hold

Company Overview

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

STAAR Surgical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
81st Percentile Overall Score

STAA MarketRank™: 

STAAR Surgical scored higher than 81% of companies evaluated by MarketBeat, and ranked 188th out of 917 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    STAAR Surgical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 9 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    STAAR Surgical has only been the subject of 4 research reports in the past 90 days.

  • Read more about STAAR Surgical's stock forecast and price target.
  • Earnings Growth

    Earnings for STAAR Surgical are expected to grow in the coming year, from ($1.14) to ($0.04) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of STAAR Surgical is -45.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of STAAR Surgical is -45.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    STAAR Surgical has a P/B Ratio of 2.36. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about STAAR Surgical's valuation and earnings.
  • Percentage of Shares Shorted

    12.54% of the outstanding shares of STAAR Surgical have been sold short.
  • Short Interest Ratio / Days to Cover

    STAAR Surgical has a short interest ratio ("days to cover") of 5.3.
  • Change versus previous month

    Short interest in STAAR Surgical has recently decreased by 0.16%, indicating that investor sentiment is improving.
  • Dividend Yield

    STAAR Surgical does not currently pay a dividend.

  • Dividend Growth

    STAAR Surgical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    12.54% of the outstanding shares of STAAR Surgical have been sold short.
  • Short Interest Ratio / Days to Cover

    STAAR Surgical has a short interest ratio ("days to cover") of 5.3.
  • Change versus previous month

    Short interest in STAAR Surgical has recently decreased by 0.16%, indicating that investor sentiment is improving.
  • News Sentiment

    STAAR Surgical has a news sentiment score of 1.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.70 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 14 news articles for STAAR Surgical this week, compared to 6 articles on an average week.
  • Search Interest

    7 people have searched for STAA on MarketBeat in the last 30 days. This is an increase of 17% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, STAAR Surgical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $23,957,807.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 1.00% of the stock of STAAR Surgical is held by insiders.

  • Percentage Held by Institutions

    96.70% of the stock of STAAR Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about STAAR Surgical's insider trading history.
Receive STAA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter.

STAA Stock News Headlines

Elon just did WHAT!?
As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.
See More Headlines

STAA Stock Analysis - Frequently Asked Questions

STAAR Surgical's stock was trading at $24.29 on January 1st, 2025. Since then, STAA shares have decreased by 23.0% and is now trading at $18.7040.
View the best growth stocks for 2025 here
.

STAAR Surgical (NASDAQ:STAA) issued its quarterly earnings results on Wednesday, August, 7th. The medical instruments supplier reported $0.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.24 by $0.09. The company's quarterly revenue was up 7.3% on a year-over-year basis.
Read the conference call transcript
.

STAAR Surgical's board approved a stock buyback plan on Friday, May 16th 2025, which authorizes the company to repurchase $30,000,000 in shares, according to EventVestor. This means that the company could buy up to 3.2% of its stock through open market purchases. Stock buyback plans are often a sign that the company's board believes its shares are undervalued.

STAAR Surgical subsidiaries include Canon Staar, Frigitronics Inc., STAAR Japan Inc., STAAR Optical Equipment, STAAR Surgical AG, STAAR Surgical PTE. LTD, and Technology (Shanghai) Co. LTD.

STAAR Surgical's top institutional shareholders include Broadwood Capital Inc. (25.15%), Vanguard Group Inc. (10.94%), Armistice Capital LLC (6.06%) and Resona Asset Management Co. Ltd. (4.38%). Insiders that own company stock include Broadwood Partners, LP, James E Francese, Keith Holliday, Aimee S Weisner, Arthur C Butcher and Elizabeth Yeu Lin.
View institutional ownership trends
.

Shares of STAA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that STAAR Surgical investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), Palo Alto Networks (PANW) and JPMorgan Chase & Co. (JPM).

Company Calendar

Last Earnings
8/07/2024
Today
5/23/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Ophthalmic goods
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:STAA
Employees
960
Year Founded
1982

Price Target and Rating

Average Stock Price Target
$24.63
High Stock Price Target
$53.00
Low Stock Price Target
$16.00
Potential Upside/Downside
+31.8%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
11 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-20,210,000.00
Pretax Margin
10.26%

Debt

Sales & Book Value

Annual Sales
$279.13 million
Cash Flow
$0.81 per share
Price / Cash Flow
23.02
Book Value
$7.91 per share
Price / Book
2.36

Miscellaneous

Free Float
48,783,000
Market Cap
$925.15 million
Optionable
Optionable
Beta
0.65

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:STAA) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners